Pancreatic cancer tumor size on CT scan versus pathologic specimen: Implications for radiation treatment planning

International Journal of Radiation Oncology Biology Physics

Volumn 80, Issue 5, 2011, Pages 1383-1390

  Arvold, Nils D ^a   Niemierko, Andrzej ^b   Mamon, Harvey J ^c   Fernandez Del Castillo, Carlos ^b   Hong, Theodore S ^b  

^a HARVARD RADIATION ONCOLOGY PROGRAM   (United States)

^b MASSACHUSETTS GENERAL HOSPITAL   (United States)

^c BRIGHAM AND WOMEN S HOSPITAL   (United States)

Author keywords

CT; CTV formula; Pancreatic cancer; Pathology; Radiation

Indexed keywords

CLINICAL TARGET VOLUMES; COMPUTED TOMOGRAPHY; COMPUTED TOMOGRAPHY SCAN; CONFORMAL RADIOTHERAPY; CT; CT SCAN; CTV FORMULA; ENDOSCOPIC ULTRASOUNDS; HIGH RATE; PANCREATIC CANCERS; RADIATION TREATMENT PLANNING; SURGICAL RESECTION; TUMOR SIZE;

DISEASES; ENDOSCOPY; PATHOLOGY; RADIOTHERAPY; TOMOGRAPHY; TUMORS; ULTRASONICS;

COMPUTERIZED TOMOGRAPHY;

ADULT; ARTICLE; CANCER INVASION; CANCER RADIOTHERAPY; CANCER SURGERY; COMPUTER ASSISTED TOMOGRAPHY; DIAGNOSTIC ACCURACY; DUODENUM; ENDOSCOPIC ECHOGRAPHY; HISTOPATHOLOGY; HUMAN; INTERMETHOD COMPARISON; MAJOR CLINICAL STUDY; PANCREAS CANCER; PANCREAS SURGERY; PREOPERATIVE EVALUATION; PRIORITY JOURNAL; RETROSPECTIVE STUDY; TREATMENT PLANNING; TUMOR VOLUME; UNITED STATES;

DUODENAL NEOPLASMS; HUMANS; MIDDLE AGED; NEOPLASM INVASIVENESS; PANCREATIC NEOPLASMS; RADIOTHERAPY PLANNING, COMPUTER-ASSISTED; RADIOTHERAPY, CONFORMAL; RETROSPECTIVE STUDIES; TOMOGRAPHY, X-RAY COMPUTED; TUMOR BURDEN;

EID: 79960103189     PISSN: 03603016     EISSN: 1879355X     Source Type: Journal    
DOI: 10.1016/j.ijrobp.2010.04.058     Document Type: Article

References (30)

1. A. Jemal, R. Siegel, and E. Ward Cancer statistics, 2009 CA Cancer J Clin 59 2009 225 249
2. J.F. Griffin, S.R. Smalley, and W. Jewell Patterns of failure after curative resection of pancreatic carcinoma Cancer 66 1990 56 61 (Pubitemid 20197085)
3. J. Hattangadi, T.S. Hong, and B.Y. Yeap Results and patterns of failure in patients treated with adjuvant combined chemoradiation therapy for resected pancreatic adenocarcinoma Cancer 115 2009 3640 3650
4. A. Van den Broeck, G. Sergeant, and N. Ectors Patterns of recurrence after curative resection of pancreatic ductal adenocarcinoma Eur J Surg Oncol 35 2009 600 604
5. M.H. Kalser, and S.S. Ellenberg Pancreatic cancer. Adjuvant combined radiation and chemotherapy following curative resection Arch Surg 120 1985 899 903 (Pubitemid 15040883)
6. Gastrointestinal Tumor Study Group Further evidence of effective adjuvant combined radiation and chemotherapy following curative resection of pancreatic cancer Cancer 59 1987 2006 2010
7. C.G. Willett, B.G. Czito, and J.C. Bendell Locally advanced pancreatic cancer J Clin Oncol 23 2005 4538 4544 (Pubitemid 46196584)
8. E. Ben-Josef, A.F. Shields, and U. Vaishampayan Intensity-modulated radiotherapy (IMRT) and concurrent capecitabine for pancreatic cancer Int J Radiat Oncol Biol Phys 59 2004 454 459 (Pubitemid 38622600)
9. T. Okusaka, Y. Ito, and H. Ueno Phase II study of radiotherapy combined with gemcitabine for locally advanced pancreatic cancer Br J Cancer 91 2004 673 677 (Pubitemid 39141622)
10. H. Shinchi, S. Takao, and H. Noma Length and quality of survival after external-beam radiotherapy with concurrent continuous 5-fluorouracil infusion for locally unresectable pancreatic cancer Int J Radiat Oncol Biol Phys 53 2002 146 150 (Pubitemid 34465818)
11. C.H. Crane, R.A. Wolff, and J.L. Abbruzzese Combining gemcitabine with radiation in pancreatic cancer: Understanding important variables influencing the therapeutic index Semin Oncol 28 2001 25 33 (Pubitemid 32757657)
12. A.C. Koong, Q.T. Le, and A. Ho Phase I study of stereotactic radiosurgery in patients with locally advanced pancreatic cancer Int J Radiat Oncol Biol Phys 58 2004 1017 1021 (Pubitemid 38314781)
13. A.C. Koong, E. Christofferson, and Q.T. Le Phase II study to assess the efficacy of conventionally fractionated radiotherapy followed by a stereotactic radiosurgery boost in patients with locally advanced pancreatic cancer Int J Radiat Oncol Biol Phys 63 2005 320 323 (Pubitemid 41317146)
14. D. Schellenberg, K.A. Goodman, and F. Lee Gemcitabine chemotherapy and single-fraction stereotactic body radiotherapy for locally advanced pancreatic cancer Int J Radiat Oncol Biol Phys 72 2008 678 686
15. D.T. Chang, D. Schellenberg, and J. Shen Stereotactic radiotherapy for unresectable adenocarcinoma of the pancreas Cancer 115 2009 665 672
16. K.M. Horton Multidetector CT and three-dimensional imaging of the pancreas: State of the art J Gastrointest Surg 6 2002 126 128 (Pubitemid 40433561)
17. J.C. Wong, and D.S. Lu Staging of pancreatic adenocarcinoma by imaging studies Clin Gastroenterol Hepatol 6 2008 1301 1308
18. G.W. Boland, M.E. O'Malley, and M. Saez Pancreatic-phase versus portal vein-phase helical CT of the pancreas: Optimal temporal window for evaluation of pancreatic adenocarcinoma AJR Am J Roentgenol 172 1999 605 608 (Pubitemid 29102112)
19. J. DeWitt, B. Devereaux, and M. Chriswell Comparison of endoscopic ultrasonography and multidetector computed tomography for detecting and staging pancreatic cancer Ann Intern Med 141 2004 753 763
20. M.F. Muller, C. Meyenberger, and P. Bertschinger Pancreatic tumors: Evaluation with endoscopic US, CT, and MR imaging Radiology 190 1994 745 751 (Pubitemid 24071041)
21. P. Legmann, O. Vignaux, and B. Dousset Pancreatic tumors: Comparison of dual-phase helical CT and endoscopic sonography AJR Am J Roentgenol 170 1998 1315 1322 (Pubitemid 28210952)
22. J.H. Muler, C.J. McGinn, and D. Normolle Phase I trial using a time-to-event continual reassessment strategy for dose escalation of cisplatin combined with gemcitabine and radiation therapy in pancreatic cancer J Clin Oncol 22 2004 238 243 (Pubitemid 41095087)
23. A.Y. Minn, D. Schellenberg, and P. Maxim Pancreatic tumor motion on a single planning 4D-CT does not correlate with intrafraction tumor motion during treatment Am J Clin Oncol 32 2009 364 368
24. J.M. Metz, A. Kassaee, and M. Ingram First report of real-time tumor tracking in the treatment of pancreatic cancer using the Calypso system [Abstract] Int J Radiat Oncol Biol Phys 75 2009 S54 S55
25. A. Brade, J. Brierley, and A. Oza Concurrent gemcitabine and radiotherapy with and without neoadjuvant gemcitabine for locally advanced unresectable or resected pancreatic cancer: A phase I-II study Int J Radiat Oncol Biol Phys 67 2007 1027 1036
26. M. Hoyer, H. Roed, and L. Sengelov Phase-II study on stereotactic radiotherapy of locally advanced pancreatic carcinoma Radiother Oncol 76 2005 48 53 (Pubitemid 41096514)
27. J.D. Murphy, S. Adusumilli, and K.A. Griffith Full-dose gemcitabine and concurrent radiotherapy for unresectable pancreatic cancer Int J Radiat Oncol Biol Phys 68 2007 801 808 (Pubitemid 46818734)
28. J.D. Murphy, S. Dieterich, and D.T. Chang Duodenal toxicity in single-fraction stereotactic body radiotherapy [Abstract] Int J Radiat Oncol Biol Phys 75 2009 S29 S30
29. C.A. Iacobuzio-Donahue, B. Fu, and S. Yachida DPC4 gene status of the primary carcinoma correlates with patterns of failure in patients with pancreatic cancer J Clin Oncol 27 2009 1806 1813
30. B. Agarwal, A.M. Correa, and L. Ho Survival in pancreatic carcinoma based on tumor size Pancreas 36 2008 e15 e20